Stalfelt AM - Search Results

1

Treating acute leukaemias--a venture into economic uncertainty? A method for estimating the cost of treating patients with acute myelocytic leukaemia.

Brodin H, Stalfelt AM. Brodin H, et al. Among authors: stalfelt am. Acta Oncol. 1993;32(5):501-5. doi: 10.3109/02841869309096108. Acta Oncol. 1993. PMID: 8217233

2

Cost analysis of different phases of acute myeloid leukaemia.

Stalfelt AM, Brodin H, Wadman B. Stalfelt AM, et al. Leuk Res. 1994 Oct;18(10):783-90. doi: 10.1016/0145-2126(94)90061-2. Leuk Res. 1994. PMID: 7934137

3

Costs over time in conventional treatment of acute myeloid leukaemia. A study exploring changes in treatment strategies over two decades.

Stalfelt AM, Brodin H. Stalfelt AM, et al. J Intern Med. 1994 Oct;236(4):401-9. doi: 10.1111/j.1365-2796.1994.tb00816.x. J Intern Med. 1994. PMID: 7931043

4

The final phase in acute myeloid leukaemia (AML). A study on bleeding, infection and pain.

Stalfelt AM, Brodin H, Pettersson S, Eklöf A. Stalfelt AM, et al. Leuk Res. 2003 Jun;27(6):481-8. doi: 10.1016/s0145-2126(02)00262-x. Leuk Res. 2003. PMID: 12648506

5

The final phase in acute myeloid leukaemia (AML): a study of cause of death, place of death and type of care during the last week of life.

Stalfelt AM, Brodin H, Pettersson S, Eklöf A. Stalfelt AM, et al. Leuk Res. 2001 Aug;25(8):673-80. doi: 10.1016/s0145-2126(01)00005-4. Leuk Res. 2001. PMID: 11397472

6

Quality of life during induction treatment of acute myeloid leukaemia. A comparison of three intensive chemotherapy regimens using three instruments for quality of life assessment.

Stalfelt AM. Stalfelt AM. Acta Oncol. 1994;33(5):477-85. doi: 10.3109/02841869409083922. Acta Oncol. 1994. PMID: 7917359 Clinical Trial.

7

Quality of life of patients with acute myeloid leukaemia.

Stalfelt AM. Stalfelt AM. Leuk Res. 1994 Apr;18(4):257-67. doi: 10.1016/0145-2126(94)90028-0. Leuk Res. 1994. PMID: 8170170

8

Assessing quality of life in leukemia: presentation of an instrument for assessing quality of life in patients with blood malignancies.

Stalfelt AM, Wadman B. Stalfelt AM, et al. Qual Assur Health Care. 1993 Sep;5(3):201-11. doi: 10.1093/intqhc/5.3.201. Qual Assur Health Care. 1993. PMID: 8260638

9

Quality of life in young patients with chronic myelocytic leukaemia during intensive treatment including interferon.

Stalfelt AM, Zettervall O. Stalfelt AM, et al. Leuk Res. 1997 Aug;21(8):775-83. doi: 10.1016/s0145-2126(97)00026-x. Leuk Res. 1997. PMID: 9379685 Clinical Trial.

10

A Randomized Comparison of Doxorubicin and Doxorubicin-DNA in the Treatment of Acute NonLymphoblastic Leukemia.

Paul C, Tidefelt U, Gahrton G, Björkholm M, Järnmark M, Killander A, Kimby E, Liliemark J, Lindeberg A, Lindquist R, Lockner D, Lönnqvist B, Mellstedt H, Merk K, Palmblad J, Peterson C, Simonsson B, Stalfelt AM, Sundström C, Wadman B, Wedelin C, Udén AM, Öberg G, Öst Å. Paul C, et al. Among authors: stalfelt am. Leuk Lymphoma. 1991;3(5-6):355-64. doi: 10.3109/10428199109070279. Leuk Lymphoma. 1991. PMID: 27467426

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters